Dose Escalation of Busulfan with Pentoxifylline and Ciprofloxacin in Patients with Breast Cancer Undergoing Autologous Transplants

Publisher： Karger

E-ISSN： 1423-0232|67|5-6|368-375

ISSN： 0030-2414

Source： Oncology, Vol.67, Iss.5-6, 2005-02, pp. : 368-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?

By Cheng Yee Chung   Ueno Naoto T  

Women's Health, Vol. 6, Iss. 4, 2010-07 ,pp. : 481-485

Future Medicine

Access to resources Recommend Favorite

Biological Effects of Pegfilgrastim on Circulating Neutrophils in Breast Cancer Patients Undergoing Dose-Dense Chemotherapy

By  

Oncology, Vol. 75, Iss. 3-4, 2008-10 ,pp. : 237-244

Karger

Access to resources Recommend Favorite

Dose Escalation Study for Defining the Maximum Tolerated Dose of Continuous Oral Trofosfamide in Pretreated Patients with Metastatic Lung Cancer

By  

Oncology Research and Treatment, Vol. 27, Iss. 6, 2004-12 ,pp. : 534-538

Karger

Access to resources Recommend Favorite

Dose Escalation Study of Amrubicin in Combination with Fixed-Dose Irinotecan in Patients with Extensive Small-Cell Lung Cancer

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 7-11

Karger

Access to resources Recommend Favorite

Paclitaxel, Epirubicin and Cyclophosphamide Combination in First-Line Treatment of Metastatic Breast Cancer: A Dose Escalation Study

By  

Oncology, Vol. 66, Iss. 3, 2004-06 ,pp. : 185-191

Karger

Access to resources Recommend Favorite